Potential role of molecular hydrogen therapy on oxidative stress and redox signaling in chronic kidney disease
Authors:
Open Access
- 24 May 2024
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 176, 116802
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology, Taiwan (112-2314-B-303-018 -MY3)
- Taipei Tzu Chi Hospital
- Ministry of Science and Technology
- Buddhist Tzu Chi Medical Foundation (3/3)
- Buddhist Tzu Chi Medical Foundation (1/3)
- Buddhist Tzu Chi Medical Foundation (TCRD-TPE-111-01)
- Buddhist Tzu Chi Medical Foundation (TCRD-TPE-113-RT-3)
- National Science and Technology Council
This publication has 227 references indexed in Scilit:
- Prospects of molecular hydrogen in cancer prevention and treatmentJournal of Cancer Research and Clinical Oncology, 2024
- An Activity‐Based Ratiometric Fluorescent Probe for In Vivo Real‐Time Imaging of Hydrogen MoleculesAngewandte Chemie International Edition, 2021
- FOXO transcription factors in antioxidant defenseIUBMB Life, 2021
- Hydrogen‐rich water alleviates cyclosporine A‐induced nephrotoxicity via the Keap1/Nrf2 signaling pathwayJournal of Biochemical and Molecular Toxicology, 2020
- GPX4 at the Crossroads of Lipid Homeostasis and FerroptosisProteomics, 2019
- The temporal dynamics of structure and content in sentence comprehension: Evidence from fMRI‐constrained MEGHuman Brain Mapping, 2018
- Oxidative stress in chronic kidney diseasePediatric Nephrology, 2018
- The Emerging Role of Mitochondrial Targeting in Kidney Disease2016
- FoxO Transcription Factors Support Oxidative Stress Resistance in Human ChondrocytesArthritis & Rheumatology, 2014
- Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.The EMBO Journal, 1991